Menostar: a low-dose estrogen patch for osteoporosis
Obstetrics and Gynecology 105(2): 432-433
2005
ISSN/ISBN: 0029-7844 PMID: 15684177 Document Number: 585907
Document emailed within 1 workday
Related Documents
Walsh, M.N. 2000: In an article last summer, you mentioned that a 0.3 milligram daily dose of estrogen is effective in preventing osteoporosis. Is a dose that low also effective for preventing heart disease? Health News 6(3): 10Hayashi, T.; Taki, Y.; Ikai, K.; Hiura, M.; Kiriyama, T. 1987: Hormonal environment following treatment with a small dose of estrogen--small dose of estrogen alone and in combination with an anti-androgen Hinyokika Kiyo. Acta Urologica Japonica 33(7): 1035-1042
Kaunitz, A.; Archer, D.; Foegh, M. 2012: Safety and tolerability of the agile patch, a contraceptive patch with low-dose ethinyl estradiol (EE) and levonorgestrel (LNG), vs. combination oral contraceptives (COCs) in obese vs. non-obese women Fertility and Sterility 98(3): S195-S196
Takano, N.; Kimura, J.; Okada, H. 1982: Defective estrogen receptor in uteri of rats treated neonatally with a high dose of estrogen Nihon Sanka Fujinka Gakkai Zasshi 34(3): 391-395
Jarupanich, T.; Lamlertkittikul, S.; Chandeying, V. 2003: Efficacy, safety and acceptability of a seven-day, transdermal estradiol patch for estrogen replacement therapy Journal of the Medical Association of Thailand 86(9): 836-845
Mizunuma, H. 2004: Treatment of osteoporosis with estrogen Nihon Rinsho. Japanese Journal of Clinical Medicine 62(Suppl 2): 397-403
Lessing, J.; Glazer, E.; Peyser, M.R. 1986: Estrogen replacement therapy for postmenopausal osteoporosis Harefuah 111(7-8): 186-188
Gerber, N.J.; Rey, B. 1991: Postmenopausal osteoporosis: are there alternatives to estrogen/gestagen substitution? Schweizerische Rundschau für Medizin Praxis 80(16): 423-427
Ettinger, B. 1986: Preventing postmenopausal osteoporosis with estrogen replacement therapy International Journal of Fertility 31(3 Suppl Estrogen ): 15-20
Meczekalski, B.ła.; Czyzyk, A. 2009: Selective estrogen receptor modulators in treatment of postmenopausal osteoporosis Ginekologia Polska 80(3): 213-217
Blanc, B.; Cravello, L.; Micheletti, M.C.; d'Ercole, C.; Zartarian, M. 1998: Continuous hormone replacement therapy for menopause combining nomegestrol acetate and gel, patch, or oral estrogen: a comparison of amenorrhea rates Clinical Therapeutics 20(5): 901-912
Buffo, L.; Rossini, M.; Buoncristiano, A.; Girardello, S.; Zamberlan, N.; Diani, F.; Adami, S. 1996: Diphosphonates: and alternative to estrogen therapy in postmenopausal osteoporosis. Experience with alendronate Minerva Ginecologica 48(6): 263-272
Palma, L.F. 1982: Family Practice Grand Rounds. Postmenopausal osteoporosis and estrogen therapy: who should be treated? Journal of Family Practice 14(2): 355-359
Ohta, H. 2008: Evidence for the selective estrogen receptor modulator raloxifene: its evolving role in the treatment of osteoporosis Clinical Calcium 18(10): 1442-1450
LaGuardia, K.D. 2014: Low-dose levonorgestrel and ethinyl estradiol patch and pill: a randomized controlled trial Obstetrics and Gynecology 123(5): 1107-1108
LaGuardia, K.D. 2014: Low-dose levonorgestrel and ethinyl estradiol patch and pill: a randomized controlled trial Obstetrics and Gynecology 123(5): 1107-1108
LaGuardia, K.D. 2014: Low-dose levonorgestrel and ethinyl estradiol patch and pill: a randomized controlled trial Obstetrics and Gynecology 123(5): 1107-1108
Dale, L.C.; Hurt, R.D.; Offord, K.P.; Lawson, G.M.; Croghan, I.T.; Schroeder, D.R. 1995: High-dose nicotine patch therapy. Percentage of replacement and smoking cessation JAMA 274(17): 1353-1358
Kaunitz, A.M.; Portman, D.; Westhoff, C.L.; Archer, D.F.; Mishell, D.R.; Foegh, M. 2015: Self-reported and verified compliance in a phase 3 clinical trial of a novel low-dose contraceptive patch and pill Contraception 91(3): 204-210
Bunyaratavej, N. 2011: Recommended dose of alfacacidol for osteoporosis Journal of the Medical Association of Thailand 94 Suppl. 5: S7-S9